These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 22721571)

  • 21. A randomised controlled trial of financial incentives to increase hepatitis B vaccination completion among people who inject drugs in Australia.
    Topp L; Day CA; Wand H; Deacon RM; van Beek I; Haber PS; Shanahan M; Rodgers C; Maher L;
    Prev Med; 2013 Oct; 57(4):297-303. PubMed ID: 23639625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Applying a stigma and time framework to facilitate equitable access to hepatitis C care among women who inject drugs: The ETHOS Engage Study.
    Marshall AD; Rance J; Dore GJ; Grebely J; Treloar C
    Int J Drug Policy; 2024 Jul; 129():104477. PubMed ID: 38861842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preventing hepatitis C: 'common sense', 'the bug' and other perspectives from the risk narratives of people who inject drugs.
    Davis M; Rhodes T; Martin A
    Soc Sci Med; 2004 Nov; 59(9):1807-18. PubMed ID: 15312916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Knowledge and attitudes towards hepatitis C and injecting drug use among mental-health support workers of a community managed organisation.
    Rose G; Cama E; Brener L; Treloar C
    Aust Health Rev; 2013 Nov; 37(5):654-9. PubMed ID: 24160716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beyond cure: patient reported outcomes of hepatitis C treatment among people who inject drugs in Australia.
    Madden A; Hopwood M; Neale J; Treloar C
    Harm Reduct J; 2018 Aug; 15(1):42. PubMed ID: 30111327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV and viral hepatitis C coinfection in people who inject drugs: implications of new direct acting antivirals for hepatitis C virus treatment.
    Walsh N; Maher L
    Curr Opin HIV AIDS; 2012 Jul; 7(4):339-44. PubMed ID: 22498482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors influencing health care-seeking behaviours among Mayan women in Guatemala.
    Schooley J; Mundt C; Wagner P; Fullerton J; O'Donnell M
    Midwifery; 2009 Aug; 25(4):411-21. PubMed ID: 18053623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Promoting treatment for hepatitis C in people who inject drugs: A review of the barriers and opportunities.
    Pedlar A; Sandhu PJ
    J Am Assoc Nurse Pract; 2020 Aug; 32(8):563-568. PubMed ID: 31425374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of case management on rural women's quality of life and substance use.
    Passey M; Sheldrake M; Leitch K; Gilmore V
    Rural Remote Health; 2007; 7(3):710. PubMed ID: 17683243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Barriers to effective management of hepatitis C virus in people who inject drugs: Evidence from outpatient clinics.
    Molinaro S; Resce G; Alberti A; Andreoni M; D Egidio PPF; Leonardi C; Nava FA; Pasqualetti P; Villa S
    Drug Alcohol Rev; 2019 Sep; 38(6):644-655. PubMed ID: 31441565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Midwives' descriptions of the postnatal experiences of women who use illicit substances: a descriptive study.
    Dowdell JA; Fenwick J; Bartu A; Sharp J
    Midwifery; 2009 Jun; 25(3):295-306. PubMed ID: 17614166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 'Beyond the willing & the waiting' - The role of peer-based approaches in hepatitis C diagnosis & treatment.
    Henderson C; Madden A; Kelsall J
    Int J Drug Policy; 2017 Dec; 50():111-115. PubMed ID: 28927831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequent experience of discrimination among people who inject drugs: Links with health and wellbeing.
    Couto E Cruz C; Salom CL; Dietze P; Lenton S; Burns L; Alati R
    Drug Alcohol Depend; 2018 Sep; 190():188-194. PubMed ID: 30048872
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The depiction of stigmatization in research about hepatitis C.
    Paterson BL; Backmund M; Hirsch G; Yim C
    Int J Drug Policy; 2007 Oct; 18(5):364-73. PubMed ID: 17854724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prejudice among health care workers toward injecting drug users with hepatitis C: does greater contact lead to less prejudice?
    Brener L; von Hippel W; Kippax S
    Int J Drug Policy; 2007 Oct; 18(5):381-7. PubMed ID: 17854726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characteristics of Iranian women seeking drug treatment.
    Dolan K; Salimi S; Nassirimanesh B; Mohsenifar S; Allsop D; Mokri A
    J Womens Health (Larchmt); 2011 Nov; 20(11):1687-91. PubMed ID: 21905877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Developing a framework for understanding doctors' health access: a qualitative study of Australian GPs.
    Kay M; Mitchell G; Clavarino A; Frank E
    Aust J Prim Health; 2012; 18(2):158-65. PubMed ID: 22551838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The common sense model applied to hepatitis C: a qualitative analysis of the impact of disease comparison and witnessed death on hepatitis C illness perception.
    Safo SA; Batchelder A; Peyser D; Litwin AH
    Harm Reduct J; 2015 Jun; 12():20. PubMed ID: 26092261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concordance between self-reported and actual hepatitis C virus infection status in a cohort of people who inject drugs.
    O'Keefe D; Aitken C; Higgs P; Dietze P
    Drug Alcohol Rev; 2013 Mar; 32(2):208-10. PubMed ID: 22943595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fifteen years of HIV surveillance among people who inject drugs: the Australian Needle and Syringe Program Survey 1995-2009.
    Topp L; Day CA; Iversen J; Wand H; Maher L;
    AIDS; 2011 Mar; 25(6):835-42. PubMed ID: 21192232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.